Literature DB >> 161840

[Molybdocene dichloride as an antitumor agent (author's transl)].

P Köpf-Maier, M Leitner, R Voigtländer, H Köpf.   

Abstract

The antitumor activity of molybdocene dichloride is tested against Ehrlich ascites tumor in CF1 mice. The application of 75 of 100 mg/kg 24 h after transplantation achieves 100% tumor inhibition until day 30. Following the d0 and d1 metallocene dichlorides of titanium and vanadium, molybdocene dichloride is the first analogous d2 system revealing similar antineoplastic properties.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 161840

Source DB:  PubMed          Journal:  Z Naturforsch C Biosci        ISSN： 0341-0382


  12 in total

1.  Specific Interactions of Antitumor Metallocenes with Deoxydinucleoside Monophosphates.

Authors:  Rahel P Eberle; Yvonne Hari; Stefan Schürch
Journal:  J Am Soc Mass Spectrom       Date:  2017-05-12       Impact factor: 3.109

2.  Tumor inhibition by titanocene dichloride: first clues to the mechanism of action.

Authors:  P Köpf-Maier; H Köpf
Journal:  Naturwissenschaften       Date:  1980-08

3.  [Tumor inhibition by metallocenes: effect of titanocene, zirconocene, and hafnocene dichlorides on Ehrlich ascites tumor in mice (author's transl)].

Authors:  P Köpf-Maier; B Hesse; H Köpf
Journal:  J Cancer Res Clin Oncol       Date:  1980-01       Impact factor: 4.553

4.  Intracellular mapping of the distribution of metals derived from the antitumor metallocenes.

Authors:  Jenny B Waern; Hugh H Harris; Barry Lai; Zhonghou Cai; Margaret M Harding; Carolyn T Dillon
Journal:  J Biol Inorg Chem       Date:  2005-09-23       Impact factor: 3.358

5.  Antitumor activity of ionic niobocene and molybdenocene complexes in high oxidation states.

Authors:  P Köpf-Maier; T Klapötke
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  Niobium uptake and release by bacterial ferric ion binding protein.

Authors:  Yanbo Shi; Ian Harvey; Dominic Campopiano; Peter J Sadler
Journal:  Bioinorg Chem Appl       Date:  2010-04-28       Impact factor: 7.778

7.  Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum(II) and metallocene dichlorides.

Authors:  P Köpf-Maier; W Wagner; E Liss
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

8.  Tumor inhibition by metallocenes: antitumor activity of titanocene dihalides (C5H5)2TiX2 (X=F, Cl, Br, I, NCS) and their application in buffered solutions as a method for suppressing drug-induced side effects.

Authors:  P Köpf-Maier; B Hesse; R Voigtländer; H Köpf
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

9.  In vitro cell growth inhibition by metallocene dichlorides.

Authors:  P Köpf-Maier; W Wagner; H Köpf
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

10.  Water-soluble molybdenocene complexes with both proliferative and antiproliferative effects on cancer cell lines and their binding interactions with human serum albumin.

Authors:  Idainés Feliciano; Jaime Matta; Enrique Meléndez
Journal:  J Biol Inorg Chem       Date:  2009-06-18       Impact factor: 3.358
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.